Concepts (233)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Failure | 46 | 2023 | 1204 | 4.170 |
Why?
|
| Heart-Assist Devices | 40 | 2022 | 731 | 3.870 |
Why?
|
| Cardiomyopathies | 7 | 2023 | 240 | 2.260 |
Why?
|
| Amyloidosis | 9 | 2024 | 115 | 2.230 |
Why?
|
| Hemodynamics | 18 | 2022 | 711 | 1.680 |
Why?
|
| Amyloid Neuropathies, Familial | 4 | 2022 | 25 | 1.470 |
Why?
|
| Ventricular Function, Left | 13 | 2023 | 592 | 1.200 |
Why?
|
| Pulmonary Wedge Pressure | 10 | 2021 | 108 | 0.990 |
Why?
|
| Heart Transplantation | 7 | 2023 | 705 | 0.940 |
Why?
|
| Cardiac Catheterization | 10 | 2019 | 291 | 0.830 |
Why?
|
| Prealbumin | 6 | 2023 | 34 | 0.790 |
Why?
|
| Heart Valve Diseases | 3 | 2024 | 109 | 0.770 |
Why?
|
| Diflunisal | 1 | 2020 | 1 | 0.770 |
Why?
|
| Heart Ventricles | 9 | 2020 | 760 | 0.750 |
Why?
|
| Middle Aged | 47 | 2023 | 25040 | 0.530 |
Why?
|
| Retrospective Studies | 27 | 2024 | 8496 | 0.510 |
Why?
|
| Male | 53 | 2024 | 40988 | 0.500 |
Why?
|
| Humans | 71 | 2024 | 86678 | 0.480 |
Why?
|
| Intra-Aortic Balloon Pumping | 4 | 2022 | 78 | 0.470 |
Why?
|
| Female | 50 | 2024 | 44550 | 0.450 |
Why?
|
| Aortic Valve Insufficiency | 3 | 2021 | 130 | 0.450 |
Why?
|
| Prosthesis Implantation | 3 | 2019 | 125 | 0.450 |
Why?
|
| Aged | 35 | 2024 | 18423 | 0.440 |
Why?
|
| Immunoglobulin Light-chain Amyloidosis | 2 | 2023 | 14 | 0.440 |
Why?
|
| Prospective Studies | 15 | 2022 | 4214 | 0.430 |
Why?
|
| Shock, Cardiogenic | 2 | 2021 | 95 | 0.380 |
Why?
|
| Coronary Artery Bypass | 3 | 2020 | 228 | 0.360 |
Why?
|
| Azithromycin | 1 | 2009 | 13 | 0.340 |
Why?
|
| Drug Hypersensitivity | 1 | 2009 | 37 | 0.340 |
Why?
|
| Mitral Valve Insufficiency | 2 | 2024 | 187 | 0.330 |
Why?
|
| Myocarditis | 1 | 2009 | 51 | 0.330 |
Why?
|
| Pacemaker, Artificial | 2 | 2020 | 87 | 0.320 |
Why?
|
| Echocardiography, Doppler | 3 | 2018 | 187 | 0.310 |
Why?
|
| Thromboembolism | 2 | 2018 | 119 | 0.310 |
Why?
|
| Thrombosis | 2 | 2020 | 296 | 0.300 |
Why?
|
| Device Removal | 2 | 2019 | 161 | 0.300 |
Why?
|
| Echocardiography | 6 | 2022 | 911 | 0.290 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2023 | 318 | 0.290 |
Why?
|
| Hemorrhage | 2 | 2018 | 268 | 0.280 |
Why?
|
| Cannula | 4 | 2019 | 47 | 0.270 |
Why?
|
| Treatment Outcome | 15 | 2023 | 7998 | 0.270 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 2018 | 230 | 0.270 |
Why?
|
| Heart Function Tests | 2 | 2018 | 30 | 0.260 |
Why?
|
| Cardiotonic Agents | 2 | 2019 | 88 | 0.250 |
Why?
|
| Cardiac Output | 3 | 2022 | 156 | 0.240 |
Why?
|
| Cardiac Valve Annuloplasty | 1 | 2023 | 13 | 0.240 |
Why?
|
| Anti-Bacterial Agents | 1 | 2009 | 747 | 0.230 |
Why?
|
| Atrioventricular Block | 1 | 2023 | 23 | 0.230 |
Why?
|
| Graft Rejection | 2 | 2020 | 1065 | 0.230 |
Why?
|
| Postoperative Complications | 5 | 2022 | 2207 | 0.230 |
Why?
|
| Central Venous Pressure | 2 | 2020 | 26 | 0.230 |
Why?
|
| Anticoagulants | 4 | 2019 | 408 | 0.220 |
Why?
|
| Benzoxazoles | 1 | 2022 | 4 | 0.220 |
Why?
|
| Stroke Volume | 3 | 2023 | 456 | 0.220 |
Why?
|
| Observational Studies as Topic | 1 | 2022 | 48 | 0.210 |
Why?
|
| Mononeuropathies | 1 | 2022 | 8 | 0.210 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2023 | 111 | 0.210 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2023 | 166 | 0.200 |
Why?
|
| RNA, Small Interfering | 1 | 2023 | 547 | 0.200 |
Why?
|
| Aortic Rupture | 1 | 2022 | 55 | 0.200 |
Why?
|
| Echocardiography, Three-Dimensional | 2 | 2017 | 516 | 0.200 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2022 | 93 | 0.190 |
Why?
|
| Lactic Acid | 1 | 2021 | 90 | 0.190 |
Why?
|
| Arterial Pressure | 2 | 2018 | 38 | 0.190 |
Why?
|
| Predictive Value of Tests | 6 | 2023 | 1673 | 0.190 |
Why?
|
| Aftercare | 1 | 2021 | 85 | 0.190 |
Why?
|
| Ventricular Function, Right | 2 | 2018 | 142 | 0.190 |
Why?
|
| Rare Diseases | 1 | 2020 | 59 | 0.190 |
Why?
|
| Immunosuppressive Agents | 2 | 2020 | 977 | 0.180 |
Why?
|
| Antidiuretic Hormone Receptor Antagonists | 1 | 2020 | 29 | 0.180 |
Why?
|
| Mathematical Concepts | 1 | 2020 | 18 | 0.180 |
Why?
|
| Heart | 2 | 2023 | 539 | 0.180 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2020 | 74 | 0.180 |
Why?
|
| Tachycardia, Ventricular | 1 | 2020 | 115 | 0.180 |
Why?
|
| Pulmonary Artery | 2 | 2021 | 306 | 0.180 |
Why?
|
| Electric Impedance | 1 | 2020 | 104 | 0.180 |
Why?
|
| Sternotomy | 1 | 2019 | 20 | 0.170 |
Why?
|
| Remote Sensing Technology | 1 | 2018 | 5 | 0.170 |
Why?
|
| Assisted Circulation | 1 | 2018 | 15 | 0.170 |
Why?
|
| Thyroid Diseases | 1 | 2019 | 104 | 0.170 |
Why?
|
| Transplant Recipients | 1 | 2020 | 122 | 0.170 |
Why?
|
| Counterpulsation | 1 | 2018 | 21 | 0.170 |
Why?
|
| Prognosis | 6 | 2022 | 3680 | 0.170 |
Why?
|
| Enoxaparin | 1 | 2018 | 23 | 0.160 |
Why?
|
| Catheter Ablation | 1 | 2020 | 233 | 0.160 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2018 | 51 | 0.160 |
Why?
|
| Octreotide | 1 | 2018 | 16 | 0.160 |
Why?
|
| Patient Readmission | 2 | 2019 | 329 | 0.160 |
Why?
|
| Testosterone | 1 | 2019 | 271 | 0.160 |
Why?
|
| Adult | 16 | 2020 | 25659 | 0.160 |
Why?
|
| Cardiac Resynchronization Therapy | 1 | 2019 | 68 | 0.160 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2018 | 165 | 0.160 |
Why?
|
| Cohort Studies | 6 | 2022 | 2768 | 0.160 |
Why?
|
| Aged, 80 and over | 3 | 2023 | 6513 | 0.150 |
Why?
|
| Thermodilution | 1 | 2017 | 21 | 0.150 |
Why?
|
| Secondary Prevention | 1 | 2018 | 162 | 0.150 |
Why?
|
| Ambulatory Care | 1 | 2018 | 181 | 0.150 |
Why?
|
| Endothelium, Vascular | 2 | 2010 | 435 | 0.150 |
Why?
|
| Clinical Decision-Making | 1 | 2019 | 257 | 0.150 |
Why?
|
| Insulin Resistance | 1 | 2019 | 377 | 0.150 |
Why?
|
| Betacoronavirus | 1 | 2020 | 258 | 0.150 |
Why?
|
| Follow-Up Studies | 6 | 2018 | 3642 | 0.150 |
Why?
|
| Heart Diseases | 1 | 2018 | 290 | 0.140 |
Why?
|
| Defibrillators, Implantable | 1 | 2018 | 129 | 0.140 |
Why?
|
| Time Factors | 6 | 2020 | 5214 | 0.130 |
Why?
|
| Serotonin | 1 | 2016 | 218 | 0.130 |
Why?
|
| Kidney Failure, Chronic | 1 | 2020 | 509 | 0.130 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 1686 | 0.130 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 316 | 0.130 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 301 | 0.130 |
Why?
|
| Incidence | 4 | 2021 | 1578 | 0.120 |
Why?
|
| Hospitalization | 1 | 2019 | 851 | 0.120 |
Why?
|
| Liver Transplantation | 1 | 2022 | 1271 | 0.120 |
Why?
|
| Kidney Transplantation | 1 | 2020 | 849 | 0.110 |
Why?
|
| Hospital Mortality | 2 | 2019 | 350 | 0.110 |
Why?
|
| Risk Assessment | 2 | 2018 | 2264 | 0.110 |
Why?
|
| Carney Complex | 1 | 2012 | 2 | 0.110 |
Why?
|
| Prosthesis Design | 3 | 2019 | 278 | 0.110 |
Why?
|
| Lung | 1 | 2018 | 1169 | 0.110 |
Why?
|
| Electrocardiography | 2 | 2015 | 478 | 0.110 |
Why?
|
| Proportional Hazards Models | 3 | 2019 | 860 | 0.100 |
Why?
|
| Diabetes Mellitus | 1 | 2019 | 806 | 0.100 |
Why?
|
| Physicians | 1 | 2019 | 674 | 0.100 |
Why?
|
| Coronary Artery Disease | 1 | 2016 | 350 | 0.100 |
Why?
|
| Recurrence | 3 | 2018 | 1139 | 0.090 |
Why?
|
| Risk Factors | 5 | 2019 | 5420 | 0.090 |
Why?
|
| Decision Trees | 1 | 2010 | 63 | 0.090 |
Why?
|
| Causality | 1 | 2010 | 81 | 0.090 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2010 | 66 | 0.090 |
Why?
|
| Vasoconstrictor Agents | 1 | 2010 | 54 | 0.090 |
Why?
|
| Magnetic Resonance Imaging, Cine | 2 | 2023 | 159 | 0.090 |
Why?
|
| Diuretics | 1 | 2010 | 124 | 0.090 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2009 | 62 | 0.080 |
Why?
|
| Prevalence | 2 | 2024 | 1239 | 0.080 |
Why?
|
| Survival Rate | 3 | 2018 | 1864 | 0.080 |
Why?
|
| Azathioprine | 1 | 2009 | 125 | 0.080 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2010 | 231 | 0.080 |
Why?
|
| Prednisone | 1 | 2009 | 258 | 0.080 |
Why?
|
| Fibrinolytic Agents | 1 | 2010 | 202 | 0.080 |
Why?
|
| Aortic Valve | 2 | 2021 | 222 | 0.080 |
Why?
|
| Equipment Failure | 2 | 2018 | 119 | 0.070 |
Why?
|
| Recovery of Function | 2 | 2019 | 272 | 0.070 |
Why?
|
| Drug Therapy, Combination | 1 | 2009 | 895 | 0.070 |
Why?
|
| Glucocorticoids | 1 | 2009 | 352 | 0.070 |
Why?
|
| Comorbidity | 2 | 2020 | 944 | 0.070 |
Why?
|
| Diagnosis, Differential | 1 | 2010 | 1566 | 0.070 |
Why?
|
| Disease Progression | 2 | 2021 | 1532 | 0.070 |
Why?
|
| Amyloidosis, Familial | 1 | 2023 | 2 | 0.060 |
Why?
|
| Multicenter Studies as Topic | 1 | 2024 | 159 | 0.060 |
Why?
|
| Biomarkers | 2 | 2022 | 1718 | 0.060 |
Why?
|
| Technetium Tc 99m Pyrophosphate | 1 | 2022 | 9 | 0.060 |
Why?
|
| Immunoglobulin Light Chains | 1 | 2023 | 86 | 0.060 |
Why?
|
| Technetium | 1 | 2022 | 29 | 0.060 |
Why?
|
| Diphosphates | 1 | 2022 | 18 | 0.060 |
Why?
|
| Tricuspid Valve | 1 | 2023 | 96 | 0.060 |
Why?
|
| Gadolinium | 1 | 2023 | 103 | 0.060 |
Why?
|
| Thorax | 1 | 2023 | 75 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2023 | 318 | 0.050 |
Why?
|
| Propensity Score | 1 | 2022 | 136 | 0.050 |
Why?
|
| Waiting Lists | 1 | 2023 | 175 | 0.050 |
Why?
|
| Algorithms | 1 | 2010 | 1830 | 0.050 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 2021 | 25 | 0.050 |
Why?
|
| Axillary Artery | 1 | 2020 | 10 | 0.050 |
Why?
|
| Tissue Donors | 1 | 2023 | 464 | 0.050 |
Why?
|
| Heart Atria | 1 | 2022 | 250 | 0.050 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2020 | 44 | 0.050 |
Why?
|
| Monitoring, Physiologic | 1 | 2021 | 268 | 0.050 |
Why?
|
| Hyponatremia | 1 | 2020 | 25 | 0.050 |
Why?
|
| Aorta | 1 | 2021 | 281 | 0.050 |
Why?
|
| Euthyroid Sick Syndromes | 1 | 2019 | 11 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2018 | 1992 | 0.050 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2022 | 140 | 0.050 |
Why?
|
| Consensus | 1 | 2021 | 336 | 0.040 |
Why?
|
| Endocrine System Diseases | 1 | 2019 | 23 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2020 | 295 | 0.040 |
Why?
|
| Hyperthyroidism | 1 | 2019 | 75 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2022 | 449 | 0.040 |
Why?
|
| Immunocompromised Host | 1 | 2020 | 140 | 0.040 |
Why?
|
| Metabolic Diseases | 1 | 2019 | 48 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2023 | 1824 | 0.040 |
Why?
|
| Heparin | 1 | 2019 | 175 | 0.040 |
Why?
|
| Patient Discharge | 1 | 2021 | 300 | 0.040 |
Why?
|
| Systole | 1 | 2019 | 129 | 0.040 |
Why?
|
| Operative Time | 1 | 2019 | 127 | 0.040 |
Why?
|
| Thyrotropin | 1 | 2019 | 280 | 0.040 |
Why?
|
| Liver | 1 | 2023 | 1230 | 0.040 |
Why?
|
| Coronary Circulation | 1 | 2018 | 130 | 0.040 |
Why?
|
| Injections, Intramuscular | 1 | 2018 | 62 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 2706 | 0.040 |
Why?
|
| Contrast Media | 1 | 2023 | 1078 | 0.040 |
Why?
|
| International Normalized Ratio | 1 | 2018 | 38 | 0.040 |
Why?
|
| Thyroxine | 1 | 2019 | 344 | 0.040 |
Why?
|
| Cost of Illness | 1 | 2018 | 150 | 0.040 |
Why?
|
| Muscle Contraction | 1 | 2019 | 284 | 0.040 |
Why?
|
| Hospitals, University | 1 | 2018 | 194 | 0.040 |
Why?
|
| Hypothyroidism | 1 | 2019 | 232 | 0.040 |
Why?
|
| Delayed-Action Preparations | 1 | 2018 | 116 | 0.040 |
Why?
|
| Neutropenia | 1 | 2018 | 215 | 0.040 |
Why?
|
| Ultrasonography | 2 | 2010 | 695 | 0.040 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2018 | 134 | 0.040 |
Why?
|
| Chi-Square Distribution | 1 | 2017 | 364 | 0.040 |
Why?
|
| Risk | 1 | 2018 | 674 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2018 | 751 | 0.040 |
Why?
|
| Equipment Safety | 1 | 2016 | 31 | 0.040 |
Why?
|
| Patient Selection | 1 | 2020 | 686 | 0.040 |
Why?
|
| Reoperation | 1 | 2019 | 597 | 0.040 |
Why?
|
| Illinois | 1 | 2018 | 462 | 0.040 |
Why?
|
| Gastrointestinal Agents | 1 | 2018 | 161 | 0.030 |
Why?
|
| Prosthesis Failure | 1 | 2016 | 111 | 0.030 |
Why?
|
| Equipment Design | 1 | 2016 | 407 | 0.030 |
Why?
|
| Chicago | 1 | 2019 | 1380 | 0.030 |
Why?
|
| Cause of Death | 1 | 2016 | 277 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 861 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2018 | 1538 | 0.030 |
Why?
|
| Reference Values | 1 | 2016 | 674 | 0.030 |
Why?
|
| Exercise Test | 1 | 2015 | 164 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 1001 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 1204 | 0.030 |
Why?
|
| Observer Variation | 1 | 2016 | 603 | 0.030 |
Why?
|
| Pandemics | 1 | 2020 | 740 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 1961 | 0.030 |
Why?
|
| Sex Factors | 1 | 2016 | 1055 | 0.030 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2017 | 663 | 0.030 |
Why?
|
| Age Factors | 1 | 2016 | 1852 | 0.030 |
Why?
|
| Stroke | 1 | 2020 | 965 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2019 | 2504 | 0.020 |
Why?
|
| Mutation | 1 | 2022 | 3968 | 0.020 |
Why?
|
| Brachial Artery | 1 | 2010 | 36 | 0.020 |
Why?
|
| Exercise Tolerance | 1 | 2010 | 48 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2009 | 238 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2009 | 973 | 0.020 |
Why?
|
| United States | 1 | 2018 | 6681 | 0.020 |
Why?
|
| Adolescent | 1 | 2012 | 8984 | 0.010 |
Why?
|